Clinical Science Letters
Palmoplantar Cutaneous Reaction to Sorafenib
B. Echeverría
, B. Llombart, R. Botella-Estrada, C. Guillén
Servicio de Dermatología, Fundación Instituto Valenciano de Oncología, Valencia, Spain
Leído
5713
Vecesse ha leído el artículo
2646
Total PDF
3067
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 46 | 32 | 78 |
| 2025 5 | 76 | 49 | 125 |
| 2025 4 | 84 | 20 | 104 |
| 2025 3 | 80 | 26 | 106 |
| 2025 2 | 72 | 36 | 108 |
| 2025 1 | 63 | 24 | 87 |
| 2024 12 | 58 | 34 | 92 |
| 2024 11 | 57 | 74 | 131 |
| 2024 10 | 53 | 44 | 97 |
| 2024 9 | 57 | 33 | 90 |
| 2024 8 | 63 | 47 | 110 |
| 2024 7 | 48 | 37 | 85 |
| 2024 6 | 44 | 23 | 67 |
| 2024 5 | 39 | 36 | 75 |
| 2024 4 | 35 | 13 | 48 |
| 2024 3 | 48 | 57 | 105 |
| 2024 2 | 31 | 32 | 63 |
| 2024 1 | 35 | 34 | 69 |
| 2023 12 | 43 | 27 | 70 |
| 2023 11 | 42 | 34 | 76 |
| 2023 10 | 33 | 22 | 55 |
| 2023 9 | 38 | 21 | 59 |
| 2023 8 | 34 | 17 | 51 |
| 2023 7 | 48 | 33 | 81 |
| 2023 6 | 30 | 23 | 53 |
| 2023 5 | 56 | 14 | 70 |
| 2023 4 | 29 | 18 | 47 |
| 2023 3 | 37 | 26 | 63 |
| 2023 2 | 24 | 19 | 43 |
| 2022 1 | 23 | 48 | 71 |
| 2022 12 | 27 | 45 | 72 |
| 2022 11 | 13 | 30 | 43 |
| 2022 10 | 16 | 23 | 39 |
| 2022 9 | 13 | 39 | 52 |
| 2022 8 | 13 | 33 | 46 |
| 2022 7 | 15 | 24 | 39 |
| 2022 6 | 5 | 21 | 26 |
| 2022 5 | 14 | 30 | 44 |
| 2022 4 | 30 | 26 | 56 |
| 2022 3 | 25 | 44 | 69 |
| 2022 2 | 17 | 22 | 39 |
| 2021 1 | 20 | 34 | 54 |
| 2021 12 | 15 | 38 | 53 |
| 2021 11 | 31 | 41 | 72 |
| 2021 10 | 20 | 46 | 66 |
| 2021 9 | 19 | 40 | 59 |
| 2021 8 | 15 | 28 | 43 |
| 2021 7 | 17 | 32 | 49 |
| 2021 6 | 8 | 31 | 39 |
| 2021 5 | 9 | 18 | 27 |
| 2021 4 | 23 | 55 | 78 |
| 2021 3 | 25 | 21 | 46 |
| 2021 2 | 37 | 28 | 65 |
| 2020 1 | 12 | 13 | 25 |
| 2020 12 | 16 | 14 | 30 |
| 2020 11 | 15 | 12 | 27 |
| 2020 10 | 11 | 15 | 26 |
| 2020 9 | 9 | 14 | 23 |
| 2020 8 | 12 | 15 | 27 |
| 2020 7 | 17 | 9 | 26 |
| 2020 6 | 9 | 18 | 27 |
| 2020 5 | 10 | 15 | 25 |
| 2020 4 | 14 | 13 | 27 |
| 2020 3 | 18 | 18 | 36 |
| 2020 2 | 2 | 2 | 4 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 8 | 8 |
| 2019 11 | 0 | 2 | 2 |
| 2019 10 | 0 | 7 | 7 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 0 | 4 | 4 |
| 2019 5 | 0 | 57 | 57 |
| 2019 3 | 0 | 6 | 6 |
| 2019 2 | 0 | 3 | 3 |
| 2018 4 | 0 | 1 | 1 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 4 | 2 | 6 |
| 2018 1 | 12 | 4 | 16 |
| 2017 12 | 9 | 7 | 16 |
| 2017 11 | 11 | 2 | 13 |
| 2017 10 | 14 | 7 | 21 |
| 2017 9 | 8 | 4 | 12 |
| 2017 8 | 12 | 12 | 24 |
| 2017 7 | 14 | 3 | 17 |
| 2017 6 | 15 | 6 | 21 |
| 2017 5 | 11 | 6 | 17 |
| 2017 4 | 15 | 8 | 23 |
| 2017 3 | 17 | 4 | 21 |
| 2017 2 | 14 | 6 | 20 |
| 2016 1 | 11 | 5 | 16 |
| 2016 12 | 22 | 7 | 29 |
| 2016 11 | 24 | 6 | 30 |
| 2016 10 | 16 | 17 | 33 |
| 2016 9 | 12 | 16 | 28 |
| 2016 8 | 28 | 4 | 32 |
| 2016 7 | 11 | 5 | 16 |
| 2016 6 | 6 | 10 | 16 |
| 2016 5 | 12 | 9 | 21 |
| 2016 4 | 7 | 11 | 18 |
| 2016 3 | 4 | 8 | 12 |
| 2016 2 | 3 | 12 | 15 |
| 2015 1 | 6 | 9 | 15 |
| 2015 12 | 9 | 6 | 15 |
| 2015 11 | 12 | 14 | 26 |
| 2015 10 | 8 | 8 | 16 |
| 2015 9 | 6 | 6 | 12 |
| 2015 8 | 6 | 3 | 9 |
| 2015 7 | 13 | 7 | 20 |
| 2015 6 | 19 | 9 | 28 |
| 2015 5 | 46 | 24 | 70 |
| 2015 4 | 26 | 11 | 37 |
| 2015 3 | 18 | 11 | 29 |
| 2015 2 | 17 | 12 | 29 |
| 2015 1 | 18 | 15 | 33 |
| 2014 12 | 18 | 15 | 33 |
| 2014 11 | 13 | 10 | 23 |
| 2014 10 | 29 | 14 | 43 |
| 2014 9 | 22 | 11 | 33 |
| 2014 8 | 35 | 22 | 57 |
| 2014 7 | 41 | 22 | 63 |
| 2014 6 | 34 | 15 | 49 |
| 2014 5 | 32 | 13 | 45 |
| 2014 4 | 27 | 14 | 41 |
| 2014 3 | 30 | 11 | 41 |
| 2014 2 | 18 | 20 | 38 |
| 2014 1 | 26 | 12 | 38 |
| 2013 12 | 30 | 20 | 50 |
| 2013 11 | 22 | 18 | 40 |
| 2013 10 | 19 | 21 | 40 |
| 2013 9 | 14 | 17 | 31 |
| 2013 8 | 19 | 16 | 35 |
| 2013 7 | 18 | 24 | 42 |
| 2013 6 | 25 | 23 | 48 |
| 2013 5 | 16 | 14 | 30 |
| 2013 4 | 19 | 18 | 37 |
| 2013 3 | 21 | 16 | 37 |
| 2013 2 | 17 | 8 | 25 |
| 2013 1 | 7 | 3 | 10 |
Mostrar todo
